Cargando…

Alteration of medical therapy in patients with heart failure relative to change in symptom severity

In this observational analysis from the Practice Innovation and Clinical Excellence Registry®, we examined changes in guideline‐directed medical therapies relative to changes in symptom severity in ambulatory patients with heart failure with reduced ejection fraction, finding change in medication mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim, Nasrien E., Song, Yang, Cannon, Christopher P., Doros, Gheorghe, Russo, Patricia, Ponirakis, Angelo, Alexanian, Claire, Januzzi, James L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816058/ https://www.ncbi.nlm.nih.gov/pubmed/31268222 http://dx.doi.org/10.1002/ehf2.12480

Ejemplares similares

Heart failure with mid‐range ejection fraction: characterization of patients from the PINNACLE Registry®
por: Ibrahim, Nasrien E., et al.
Publicado: (2019)

Promoting Health Equity in Heart Failure Amid a Pandemic
por: DeFilippis, Ersilia M., et al.
Publicado: (2021)

Gene Expression and Levels of TGF-B in PBMC Is Associated with Severity of Symptoms in Chronic Heart Failure
por: Saadati, Samaneh, et al.
Publicado: (2020)

Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms
por: Saad, Farid, et al.
Publicado: (2018)

Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study
por: Revuelta‐López, Elena, et al.
Publicado: (2020)

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
por: Tahir, Usman A., et al.
Publicado: (2019)

Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan
por: Ibrahim, Nasrien E., et al.
Publicado: (2020)

Signs, symptoms, and treatment patterns across serial ambulatory cardiology visits in patients with heart failure: insights from the NCDR PINNACLE® registry
por: Allen, Larry A., et al.
Publicado: (2018)

Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
por: Ibrahim, Nasrien E., et al.
Publicado: (2020)

Both intermuscular fat and LVEF decline promote heart failure symptoms in cancer survivors
por: Reding, Kerryn W., et al.
Publicado: (2021)

Habits Heart App for Patient Engagement in Heart Failure Management: Pilot Feasibility Randomized Trial
por: Wei, Kevin S, et al.
Publicado: (2021)

Relationship between the spread of COVID-19, social frailty, and depressive symptoms in patients with heart failure
por: Shakuta, Saki, et al.
Publicado: (2022)

Multiple biomarker panel to screen for severe aortic stenosis: results from the CASABLANCA study
por: Elmariah, Sammy, et al.
Publicado: (2018)

Finding a Needle in a Haystack: Proteomics in Heart Failure
por: Michelhaugh, Sam A., et al.
Publicado: (2020)

Biomarkers in Heart Failure
por: Spineti, Pedro Pimenta de Mello
Publicado: (2019)

Long‐term administration of intravenous inotropes in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2021)

Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure
por: Sun, Weiju, et al.
Publicado: (2022)

Infections in Heart Failure - Impact on Mortality
por: Mesquita, Evandro Tinoco
Publicado: (2018)

Evaluating Sodium Restriction in Heart Failure
por: Spineti, Pedro Pimenta de Mello
Publicado: (2019)

How to consider target heart rate in patients with systolic heart failure
por: Izumida, Toshihide, et al.
Publicado: (2020)

Serial heart rate measurement and mortality after acute heart failure
por: Ancion, Arnaud, et al.
Publicado: (2019)

DNA Damage in Chronic Heart Failure: Consequences Beyond those in the Heart
por: Corrêa, Camila Renata, et al.
Publicado: (2020)

Sacubitril–valsartan in heart failure and multimorbidity patients
por: Rodil Fraile, Raquel, et al.
Publicado: (2018)

A method for establishing class III medical device equivalence: sodium hyaluronate (GenVisc 850) for the treatment of knee osteoarthritis
por: Doros, Gheorghe, et al.
Publicado: (2016)

Outcomes of a brief coping skills group intervention for adults with severe postconcussion symptoms
por: Ali, Jordan I, et al.
Publicado: (2019)

Characteristics and in-hospital outcomes of patients with acute coronary syndromes and heart failure in the United Arab Emirates
por: Shehab, Abdulla, et al.
Publicado: (2012)

A quality improvement approach to reducing hospital readmissions in patients with cancer and heart failure
por: Fadol, Anecita, et al.
Publicado: (2019)

Challenges and the innovations in the care of advanced heart failure patients during COVID-19
por: Yehya, Amin, et al.
Publicado: (2021)

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
por: Martín‐Garcia, Ana, et al.
Publicado: (2020)

Quality of Life in Heart Failure: An Important Goal in Treatment
por: Gomes, Brenno Rizerio, et al.
Publicado: (2020)

Post-Traumatic Arteriovenous Fistulas Leading to Heart Failure
por: Rabtsun, Artem, et al.
Publicado: (2021)

Heart failure is associated with an increased incidence of cancer diagnoses
por: Roderburg, Christoph, et al.
Publicado: (2021)

The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians
por: Anker, Markus S., et al.
Publicado: (2020)

Transcriptional plasticity of fibroblasts in heart disease
por: Micheletti, Rudi, et al.
Publicado: (2022)

Insulin signaling alters antioxidant capacity in the diabetic heart
por: Matsuzaki, Satoshi, et al.
Publicado: (2021)

Failure in Medical Practice: Human Error, System Failure, or Case Severity?
por: Roman, Mihai Dan, et al.
Publicado: (2022)

Impact of a ‘stent for life’ initiative on post‐ST elevation myocardial infarction heart failure: a 15 year heart failure clinic experience
por: Bayes‐Genis, Antoni, et al.
Publicado: (2017)

Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
por: D'Assante, Roberta, et al.
Publicado: (2021)

Prospective Evaluation of Association Between Negative Emotions and Heart Failure Symptom Severity
por: Lee, Kyoung Suk, et al.
Publicado: (2020)

Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction
por: Büttner, Petra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_je2can4aarjcdh1m531m8sao0j